机译:2年的吸收生物吸收血管支架的临床结果与患者患者患有急性冠状动脉综合征而稳定冠心病 - 艾达试验归档的患者患者药物洗脱金属支架
Amsterdam UMC University of AmsterdamHeart Center Academic Medical CenterAmsterdam The Netherlands;
The Department of CardiologyOnze Lieve Vrouwe GasthuisAmsterdam The Netherlands;
Amsterdam UMC University of AmsterdamHeart Center Academic Medical CenterAmsterdam The Netherlands;
The Department of CardiologyOnze Lieve Vrouwe GasthuisAmsterdam The Netherlands;
The Department of CardiologyMedical Center LeeuwardenLeeuwarden The Netherlands;
The Department of CardiologyTergooi HospitalBlaricum The Netherlands;
The Department of CardiologyAlbert Schweitzer HospitalDordrecht The Netherlands;
Amsterdam UMC University of AmsterdamHeart Center Academic Medical CenterAmsterdam The Netherlands;
Thoraxcenter Erasmus MCRotterdam The Netherlands;
NHLIImperial College LondonLondon United Kingdom;
Amsterdam UMC University of AmsterdamHeart Center Academic Medical CenterAmsterdam The Netherlands;
Amsterdam UMC University of AmsterdamHeart Center Academic Medical CenterAmsterdam The Netherlands;
Amsterdam UMC University of AmsterdamHeart Center Academic Medical CenterAmsterdam The Netherlands;
Amsterdam UMC University of AmsterdamHeart Center Academic Medical CenterAmsterdam The Netherlands;
Amsterdam UMC University of AmsterdamHeart Center Academic Medical CenterAmsterdam The Netherlands;
Amsterdam UMC University of AmsterdamHeart Center Academic Medical CenterAmsterdam The Netherlands;
Amsterdam UMC University of AmsterdamHeart Center Academic Medical CenterAmsterdam The Netherlands;
Amsterdam UMC University of AmsterdamHeart Center Academic Medical CenterAmsterdam The Netherlands;
Amsterdam UMC University of AmsterdamHeart Center Academic Medical CenterAmsterdam The Netherlands;
ACS/NSTEMI; bioabsorbable devices/polymers; stent thrombosis; stent; drug eluting;
机译:2年的吸收生物吸收血管支架的临床结果与患者患者患有急性冠状动脉综合征而稳定冠心病 - 艾达试验归档的患者患者药物洗脱金属支架
机译:Amsterdam Investigator-initiateD Absorb策略所有患者试验(AIDA试验):一项临床评估,比较了ABSORB依维莫司洗脱生物可吸收血管支架策略与XIENCE系列(XIENCE PRIME或XIENCE Xpedition)依维莫司洗脱冠状动脉支架策略的疗效和性能连续性所有患者的冠状动脉病变的治疗:原理和研究设计
机译:TCT-310 Aptimus洗脱生物可吸收血管支架随机比较的四年临床结果来自吸收中国审判的冠状动脉疾病患者患者血管内洗脱的金属支架
机译:生物可吸收聚合物雷帕霉素洗脱支架(Excel支架)对冠心病患者的临床疗效和安全性
机译:生物可吸收血管支架与金属依维莫司洗脱支架在冠状动脉疾病中的中期和长期安全性和有效性:包括5577例患者在内的7项随机对照试验的加权荟萃分析
机译:Amsterdam Investigator-initiateD Absorb Strategy All-comers试验(AIDA试验):一项临床评估,比较了ABSORB依维莫司洗脱生物可吸收性血管支架策略与XIENCE系列(XIENCE PRIME或XIENCE Xpedition)依维莫司洗脱冠状动脉支架治疗的疗效和性能来的所有患者冠状动脉病变的治疗:原理和研究设计